Population pharmacokinetics of amikacin in critically ill patients

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 7, 1996, Pages 1682-1689

  Bressolle, Francoise ^a   Gouby, Anne ^b   Martinez, Jean Marie ^a   Joubert, Pierre ^b   Saissi, Gilbert ^b   Guillaud, Robert ^b   Gomeni, Roberto ^c  

^a UNIV MONTPELLIER   (France)

^b Hopital Gaston Doumergue   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CREATININE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BAYES THEOREM; CHILD; COMPARTMENT MODEL; COMPUTER MODEL; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 0029991787     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.7.1682     Document Type: Article

References (31)

1. Belfayol, L., P. Mauran, J. M. Coulaud, P. Perrin, A. M. Bosio, and F. Fauvelle. 1995. Estimations des paramètres pharmacocinétiques de l'amikacine utilisée en dose journalière chez le patient de réanimation. J. Pharm. Clin. 14:49-52.
2. Burton, M. E., C. I. Ash, and D. P. Hill. 1991. A controlled trial of the cost benefit of computerized Bayesian aminoglycoside administration. Clin. Pharmacol. Ther. 49:685-694.
3. Burton, M. E., D. C. Brater, P. S. Chen, R. B. Day, P. J. Huber, and M. R. Vasko. 1985. A Bayesian feedback method of aminoglycoside dosing. Clin. Pharmacol. Ther. 3:349-357.
4. Cockcroft, D. W., and M. H. Gault. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-47.
5. Davey, P. G., A. M. Geddes, I. Gonda, E. S. Harpur, and D. K. Scott. 1984. Comparison of methods for estimating gentamicin clearance and retrospective analysis of changes in clearance with emphasis on patients with normal renal function. Br. J. Clin. Pharmacol. 17:147-155.
6. Davis, R. L., D. Lehmann, C. A. Stidley, and J. Neidhart. 1991. Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy. Antimicrob. Agents Chemother. 35:944-947.
7. Dechaux, M., G. Gonzalez, and M. Broyer. 1978. Créatinine plasmatique, clearance et excretion urinaire de la créatinine chez l'enfant. Arch. Fr. Pediatr. 35:53-62.
8. Dempster, A. P., N. M. Laird, and D. B. Rubin. 1977. Maximum likelihood from incomplete data via the EM algorithm. J. R. Statist. Soc. 39:1-38.
9. Draper, N., and H. Smith. 1966, Applied regression analysis. p. 171-195. John Wiley & Sons, Inc., New York.
10. Elle, E. I., and T. M. Ludden. 1995. Population pharmacokinetic modeling: the importance of informative graphics. Pharm. Res. 12:1845-1855.
11. Fagon, J. Y., J. Chastre, A. G. Hance, M. Guiguet, J. Trouillet, Y. Domart, J. Pieere, and C. Gilbert. 1988. Detection of nosocomial lung infection in ventiled patients. Am. Rev. Respir. Dis. 138:110-116.
12. Franson, T. R., E. J. Quebbeman, J. Whipple, R. Thomson, J. Bubrick, S. L. Rosenberger, and R. K. Ausman. 1988. Prospective comparison of traditional and pharmacokinetic dosing of aminoglycosides. Crit. Care Med. 16:840-843.
13. Garraffo, R., A. Iliadis, J. P. Cano, P. Dellamonica, and P. Lapalus. 1989. Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin. J. Pharm. Sci. 78:753-757.
14. Gomeni, R., G. Pineau, and F. Mentré. 1994. Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package. Anticancer Res. 14:2321-2326.
15. Hickling, K., E. Begg, and M. L. Moore. 1989. A prospective randomised trial comparing individualized pharmacokinetic dosage prediction for aminoglycosides with prediction based on estimated creatinine clearance in critically ill patients. Intensive Care Med. 15:233-237.
16. Hurst, A. K., M. A. Yoshinaga, G. H. Mitani, K. A. F. Too, R. W. Jelliffe, and E. C. Harrison. 1990. Application of a Bayesian method to monitor and adjust vancomycin dosage regimens, Antimicrob. Agents Chemother. 34: 1165-1171.
17. Isaksson, B., L. Nilsson, R. Maller, and L. Soren. 1988. Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method. J. Antimicrob. Chemother. 22:23-33.
18. Kummana, C. R., and K. Y. Yuen. 1994. Parenteral aminoglycoside therapy. Selection, administration and monitoring. Drugs 47:902-913.
19. Lacarelle, B., L. C. Granthil, J. C. Manelli, N. Brader, G. François, and J. P. Cano. 1987. Evaluation of a Bayesian method of amikacin dosing in intensive care. Ther. Drug. Monit. 9:155-160.
20. Lenert, L. A., H. Klostermann, K. W. Coleman, J. Lurie, und F. Blaschke. 1992. Practical computer-assisted dosing for aminoglycoside antibiotics. Antimicrob. agents Chemother. 36:1230-1235.
21. Marik, P. E., I. Havlik, F. S. E. Monteagudo, and J. Lipman. 1991. The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens. J. Antimicrob. Chemother. 27(Suppl. C):81-89.
22. Mentré, F., and R. Gomeni. 1995. A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics. J. Biopharm. Statist. 5:141-158.
23. Moore, R. D., P. S. Lietman, and C. R. Smith. 1987. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J. Infect. Dis. 155:93-99.
24. Sheiner, L. B., and S. L. Beal. 1981. Some suggestions for measuring predictive performance. J. Pharmacokinet. Biopharm. 9:503-512.
25. Sheiner, L. B., and S. L. Beal. 1981. Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data. J. Pharmacokinet. Biopharm. 9:635-651.
26. SIMED. 1994. P-PHARM user's guide, 3rd ed. SlMED, Créteil, France.
27. Sokal, R. R., and J. R. N., Rohlf. 1969. Biometry. W. H. Freeman & Co., San Francisco.
28. Traub, S. L., and C. E. Johnson. 1980. Comparison of methods of estimating creatinine clearance in children. Am. J. Hosp. Pharm. 37:195-200.
29. Trujillo, H., J. Robledo, C. Robledo, D. Espinal, G. Garces, J. Mejia, C. Restrepo, F. Restrepo, G. I. M. Rodriguez, and C. T. Guitierrez. 1991. Single daily dose amikacin in paediatric patients with severe gram-negative infections. J. Antimicrob. Chemother. 27(Suppl. C):141-147.
30. Van der Auwera, P. 1991. Pharmacokinetic evaluation of single daily dose amikacin. J. Antimicrob. Chemother. 27(Suppl. C):63-71.
31. Zaske, D. E., R. J. Cipolle, J. C. Rotschafer, L. D. Solem, N. R. Mosier, and R. G. Strate. 1982. Gentamicin pharmacokinetics in 1640 patients. Method for control of serum concentrations. Antimicrob. Agents Chemother. 21: 407-411.